Gut microbiota imbalance linked to higher UTI risks in women

FHS
June 7, 2024
2:14 am

Study reveals that gut microbial dysbiosis and frequent antibiotic use are key risk factors for recurrent urinary tract infections (UTIs) in women, emphasizing the importance of a healthy lifestyle and dietary supplements to prevent UTIs.

BD wins FDA approval for cervical cancer screening self-collection kit

Dive Brief: BD said Wednesday it has received Food and Drug Administration approval for a kit for self-collection of specimens for human papillomavirus (HPV) testing.

May 17, 2024

Women face higher mental health challenges after cardiac arrest, study finds

Cardiac arrests affect around 350,000 people in Europe each year with less than 20% surviving an out of hospital cardiac arrest.

July 9, 2024

Tirzepatide Wins FDA Approval for Weight Loss

The FDA approved tirzepatide (Zepbound), the latest injectable for chronic weight management in adults, the agency announced on Wednesday. The combination glucagon-like peptide-1 (GLP-1) and

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.